Combining the Disease Risk Index (DRI) and Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Provides a Comprehensive Prognostic Model for CD34- Selected Allogeneic HCT Christina Cho, Patrick Hilden, Scott T. Avecilla, Juliet N. Barker, Hugo Castro-Malaspina, Sergio A. Giralt, Ann A. Jakubowski, Guenther Koehne, Molly Maloy, Richard Meagher, Richard J. O'Reilly, Esperanza B. Papadopoulos, Jonathan U. Peled, Doris M. Ponce, Roni Tamari, Marcel R.M. van den Brink, James W. Young, Pere Barba, Miguel-Angel Perales Biology of Blood and Marrow Transplantation Volume 23, Issue 3, Pages S49-S50 (March 2017) DOI: 10.1016/j.bbmt.2016.12.013 Copyright © 2016 Terms and Conditions
Figure 1 Univariate and Multivariate Analyses of Factors Associated with RFS and OS after TCD PBSCT. Biology of Blood and Marrow Transplantation 2017 23, S49-S50DOI: (10.1016/j.bbmt.2016.12.013) Copyright © 2016 Terms and Conditions
Figure 2 Survival after TCD PBSCT by DRI and HCT-CI. Biology of Blood and Marrow Transplantation 2017 23, S49-S50DOI: (10.1016/j.bbmt.2016.12.013) Copyright © 2016 Terms and Conditions